search
Back to results

Dexamethasone Compared to Ondansetron and Dexamethasone for Prophylaxis of Postoperative Vomiting in Children (vomiting)

Primary Purpose

Vomiting Postoperative

Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Dexamethasone and ondasetron
Dexamethasone
Sponsored by
Instituto Materno Infantil Prof. Fernando Figueira
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Vomiting Postoperative focused on measuring Nausea and Vomiting, Vomiting, Postoperative, Anesthesia

Eligibility Criteria

1 Year - 10 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA I or II
  • Patients aged between 1 and 10 years old
  • Patients undergoing general anesthesia for surgical repair of hernia, cryptorchidism and phimosis

Exclusion Criteria:

  • Officials who refused to sign the consent form
  • ASA ≥ III
  • History of allergy to dexamethasone and/or ondansetron
  • Patients taking opioids preoperatively
  • Patients using antiemetic drugs preoperatively
  • Patients with vomiting preoperatively

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Placebo Comparator

    Placebo Comparator

    Arm Label

    Dexamethasone

    Dexamethasone and ondasetron

    Arm Description

    Children randomized to this group received a 10 ml syringe containing dexamethasone (0.15 mg / kg) at the beginning of the procedure.

    Children randomized to this group received a 10 ml syringe containing dexamethasone (0.15 mg / kg dose of 5mg ceiling) and ondansetron (0.1 mg / kg dose of 4mg ceiling)at the beginning of the procedure.

    Outcomes

    Primary Outcome Measures

    Postoperative vomiting
    Compare the incidence of vomiting in children who received dexamethasone or dexamethasone combined with ondansetron or placebo for antiemetic prophylaxis in ambulatory surgery.

    Secondary Outcome Measures

    delayed discharge
    Determine the relationship between the incidence of vomiting and the presence or absence of risk factors (duration ≥ 30 minutes of surgery, age ≥ 3 years and positive history in their own or relatives of postoperative vomiting). To determine the association between pain in the immediate postoperative period and the incidence of postoperative vomiting To determine the association between postoperative vomiting and delayed discharge

    Full Information

    First Posted
    February 15, 2011
    Last Updated
    August 2, 2011
    Sponsor
    Instituto Materno Infantil Prof. Fernando Figueira
    Collaborators
    Universidade Federal de Pernambuco
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01297010
    Brief Title
    Dexamethasone Compared to Ondansetron and Dexamethasone for Prophylaxis of Postoperative Vomiting in Children
    Acronym
    vomiting
    Official Title
    Dexamethasone Compared to Ondansetron and Dexamethasone for Prophylaxis of Postoperative Vomiting in Children Undergoing Ambulatory Surgery: Clinical Trial Randomized, Double Blind, Placebo-controlled
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2011
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2011 (undefined)
    Primary Completion Date
    July 2011 (Actual)
    Study Completion Date
    July 2011 (Actual)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Instituto Materno Infantil Prof. Fernando Figueira
    Collaborators
    Universidade Federal de Pernambuco

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The majority of pediatric surgery takes place in an outpatient basis. The occurrence of postoperative vomiting can lead to a delay in hospital discharge. However, the use of postoperative vomiting prophylaxis exposes patients unnecessarily to the drugs side effects and also raises the final costs of the surgical procedure. The Objective our study is Compare the incidence of postoperative vomiting between children who received dexamethasone, dexamethasone plus ondansetron or placebo for anti-emetic prophylaxis during outpatient surgery. This is a randomized, double blind, placebo-controlled study to comparing the use of dexamethasone, dexamethasone plus ondansetron and placebo for postoperative vomiting prophylaxis in children submitted to general anesthesia. Data analysis will be used is Fisher's exact test for the categorical variables and the Anova test for numerical variables as they presented Gaussian variation. The study used a significance level of 5%.
    Detailed Description
    The investigators know that a large number of pediatric surgeries are performed on an outpatient basis and the occurrence of nausea and vomiting after surgery can lead to delayed discharge and increased hospital costs. Based on this fact, the investigators find it relevant to determine the incidence of postoperative vomiting in pediatric surgery patients to assess the need for antiemetic prophylaxis in this study population being developed in the surgical ward of the Hospital das Clinicas - Federal University of Pernambuco (HC-UFPE ). The study will be conducted from March 2011 to September 2011.Pacientes pediatric ASA I and II underwent surgery in the pediatric surgical ward of the HC-UFPE. The sample size calculation was performed in the program StatCalc Epi-Info 6.04d, based on data from relevant literature and determined the presence of 44 patients in each of the three groups, totaling 132 patients in the study. Patients will be recruited in the preparation room anesthetic in surgical clinics of the Hospital for three shifts of existing pediatric surgery. After evaluation of each patient and then filled the criteria of inclusion and exclusion, those responsible will be informed about the procedures being undertaken and the possible consequences of their participation in research. Only after signing an informed consent by the person responsible will be held the allocation of patients into three groups, after opening the sealed envelope containing the selected group for that participant. These envelopes are previously prepared by a person outside the research. Therefore, the researcher has no prior knowledge of the group selected for the participant at the time of the consent solicitation. At the end of the study will fill a flowchart with the profile of the trial, including the total number of patients, the number of eligible patients, the number of those who were offered participation in the study, the number of denied and his reason the number of patients who agreed to participate. The latter will be known only after statistical analysis Randomization to each specific group will be held in accordance with a table of random numbers previously generated computer (Random Allocation Software 1.0, 2004). Independent variable Use of dexamethasone and ondansetron, or dexamethasone or placebo only Dependent Variables Incidence of postoperative vomiting; The need for antiemetic therapy in the recovery room post-anesthesia unit (PACU) Length of stay in PACU Delaying Hospital discharge All patients and their caregivers will be duly informed of the research objectives and will be included in the study only if they agree to participate and sign the Deed of Consent. The project was designed following the recommendations of Resolution 196/96 of the National Health Council and the Declaration of Helsinki for research involving human subjects (2000). In addition, the project was submitted to the Ethics Committee of the Hospital das Clinicas-UFPE and approved. Patients will receive all information regarding the advantages and disadvantages of this technique, being safeguarded the right to refuse to participate. The researchers will undertake to publish the study, regardless of the outcome.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Vomiting Postoperative
    Keywords
    Nausea and Vomiting, Vomiting, Postoperative, Anesthesia

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 3
    Interventional Study Model
    Factorial Assignment
    Masking
    ParticipantInvestigator
    Allocation
    Randomized
    Enrollment
    134 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Dexamethasone
    Arm Type
    Placebo Comparator
    Arm Description
    Children randomized to this group received a 10 ml syringe containing dexamethasone (0.15 mg / kg) at the beginning of the procedure.
    Arm Title
    Dexamethasone and ondasetron
    Arm Type
    Placebo Comparator
    Arm Description
    Children randomized to this group received a 10 ml syringe containing dexamethasone (0.15 mg / kg dose of 5mg ceiling) and ondansetron (0.1 mg / kg dose of 4mg ceiling)at the beginning of the procedure.
    Intervention Type
    Drug
    Intervention Name(s)
    Dexamethasone and ondasetron
    Other Intervention Name(s)
    Decadron and nausedron
    Intervention Description
    Patients will receive ondansetron (0.1 mg / kg dose of 4mg cap) associated with dexamethasone (0.15 mg / kg dose of 5mg ceiling) or dexamethasone (0.15 mg / kg) or placebo
    Intervention Type
    Drug
    Intervention Name(s)
    Dexamethasone
    Other Intervention Name(s)
    Decadron
    Intervention Description
    Children were randomized to this group ni initiate proceedings with a 10ml syringe containing dexamethasone (0.15 mg / kg dose of 5mg ceiling)
    Primary Outcome Measure Information:
    Title
    Postoperative vomiting
    Description
    Compare the incidence of vomiting in children who received dexamethasone or dexamethasone combined with ondansetron or placebo for antiemetic prophylaxis in ambulatory surgery.
    Time Frame
    The incidence of vomiting is seen in the anesthesia recovery room and 24 hours by phone
    Secondary Outcome Measure Information:
    Title
    delayed discharge
    Description
    Determine the relationship between the incidence of vomiting and the presence or absence of risk factors (duration ≥ 30 minutes of surgery, age ≥ 3 years and positive history in their own or relatives of postoperative vomiting). To determine the association between pain in the immediate postoperative period and the incidence of postoperative vomiting To determine the association between postoperative vomiting and delayed discharge
    Time Frame
    In-room post-anesthesia recovery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    1 Year
    Maximum Age & Unit of Time
    10 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: ASA I or II Patients aged between 1 and 10 years old Patients undergoing general anesthesia for surgical repair of hernia, cryptorchidism and phimosis Exclusion Criteria: Officials who refused to sign the consent form ASA ≥ III History of allergy to dexamethasone and/or ondansetron Patients taking opioids preoperatively Patients using antiemetic drugs preoperatively Patients with vomiting preoperatively
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Flavia Orange, Investigator
    Organizational Affiliation
    Universidade Federal de Pernambuco
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Dexamethasone Compared to Ondansetron and Dexamethasone for Prophylaxis of Postoperative Vomiting in Children

    We'll reach out to this number within 24 hrs